The paper explores how the adoption of enterprise risk management (ERM) practices influences external audit fees in large pharmaceutical firms. The results show that the mere presence of a Chief Risk Officer does not influence external audit fees. However, when we take the different ERM...

This paper investigates whether, and how, firms' Corporate Social Responsibility (CSR) Performance influences the auditors' assessment of the risk of material misstatement, whether due to fraud or error, at the financial statement level by analysing their pricing decision (i.e., audit fees)....